Panied Jacek Cieslak
FDA investigator
Appears on 1 document from 2022, mostly at sites in Poland. Most often cites written procedures; deviations (21 CFR 211.100).
- 1
- Documents on file
- 11.0
- Observations per 483
- 2022
- First seen
- 2022
- Most recent
What they cite most
From 11 observations- 21 CFR 211.100Written procedures; deviations2
- 21 CFR 211.110Sampling and testing of in-process materials and drug products1
- 21 CFR 211.125Labeling issuance1
- 21 CFR 211.160General requirements1
- 21 CFR 211.192Production record review1
- 21 CFR 211.42Design and construction features1
Activity by year
2022: 1
Where
Poland 1
Often inspects with
Is Panied Jacek Cieslak coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2022-03-22 | 483 Polpharma Biologics S.A.Mar 22, 2022 · Gdansk, Poland | Gdansk, Poland | 11 |
About this profile
What does Panied Jacek Cieslak inspect?
Panied Jacek Cieslak appears on 1 document on file covering 1 site, mostly in Poland.
What do they cite most often?
21 CFR 211.100 (written procedures; deviations), followed by 21 CFR 211.110 and 21 CFR 211.125.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Panied Jacek Cieslak is dated Mar 22, 2022.